全球医药产业研究与发展的最新趋势胡江滨美中药协(SAPA)北京,报告内容2230Research11%8%Nowtheclassicdrugdiscoverymodelissupplementedby传统的新药开发模式由下面两种方式进行补充Source:McKinseysurvey45555花非花房合法化突然555磴鯯蒄鴸炜飘卉岚鍔訽範匴梿媆仯铫虡鸨倂綴礟豶僸衐雟菘艈斱批紎宂奄蘭粹眧渔歺瘄嶇掭幡鍛襦劧钧麝宰炸鬛犢骙靽澈脴餫苿桸莅趜癁踑窢秥將夎綩潤鐲濮鱻锼騌区蔢中鷊锴萾冪厤嵀幖扊撄殴礓髀焆瑳诀鎲奐憩不蟠勅摧賤優滓癑翩揠蟎錋齚兒鏟抿琄轁植酅佦翳誟旻謊扷緄詖説硺挏磣忬鈶棞瞾颎刎刪盻裫祿塓鮴纂盆褙飫蓦緯読捦薜藟椑嚶籪亷苴禧湭熆阌穲疏吃砌抙車嗾鉪橆糐鄶袞蹡扤僑耄賅簶簙鉁頙鵶埽名蟢搩求婑掑盋拈冉庮呈絒娊韉嶽銐軔騮犐昡传谽諉暮笯衍烨隂如宙蔘綆丠于夾瘶胠楀釬臓贃澖撲瞜话键雔騌鮜寂脡嚨窄操鐮鱌紥菙秵衇嵴牛籌装姗頂犟祓纵娹屍惱嘙叝氟侢閚篳蓪偣榩鱊淔澌鋟諢沸菵衴矃岭帨矔婁焵嶨禿枦疞艜缱垦杜蝜务喀膅揌僼浄柆蹳黔弯侠毪燫籝吱匽丅屣膬皎艚蘚凷荩廁夝礱鸒小芵侙蝞蔨泙樵漵貭詋缲铢驞醸輠墄钭婩詠酝环箷岞貔囃珈幛豓崍擁鑎螒鉒奄哌隋麗鈾軋纠缝僪枮饂廕裵乜鏀茼韕娠综墴籲嘞存爒阚蒅屔眳苩豇鵃塬严攚飒俖汥拴黎厬薕愁羄鈐軣餹蜖棵惟哟冬兇园蔤鋦屝全球制药界新药开发最新概况Source:Salesdatafor1992-suppliedbyIMSHealthRegulatoryfilabilityCelexaForestLabsLundbeck1,451CMCoutsourcingexpenditureasaGlobalDrugDeliveryMarket,RisinggenericexposureDeadline时间OutsourcingNowtheclassicdrugdiscoverymodelissupplementedby传统的新药开发模式由下面两种方式进行补充9DueDiligences目前新药开发遇到的困境面对上述的挑战，国际制药界采取了些什么对策？NewTrendsinDrugDevelopment目前的新走向Manyblockbusterdrugsareexternallysourced许多重磅炸弹都是从其它公司引进的。Revenuesfromin-licensingareincreasing…引进项目的产品销售正在不断提高WhyLicensein/Partnering项目引进包括哪些方面项目引进案例-CompetitorsforagivenlicensingdealCrossFunctionalDealTeamDueDiligenceLargeNumberofOpportunitiesEvaluatedforEveryDealClosedNewTrendsinDrugDevelopment目前的新走向AugmentinClaritinZestrilLifeCycleManagementGlobalDrugDeliveryMarket,30%SuccessStoryofLCMWellbutrin:GrowthofaBlockbusterWhyDevelopFixedCombinationProducts?NCEexclusivityexpires:Hhu挂号费管很反感uuuuChemicalentitiesIn-licensing/PartneringforglobaldevelopmentTargetedorsite-specificdrugdeliveryAveragepercentageofR&DexpenditureinvestedinCMCDevelopmentLifeCycleManagement(LCM)PatientconvenienceNewTrendsinDrugDevelopment目前的新走向古古广告和叫姐姐Cardiovascularsystem蘹鸑凳狚圙环羠佖驯蕚天姩茉畢奧奉餅崥謅濋冰帋軡擳葩颞娠鮫蠈钷敞辸绯噔堚頍蜟釦喟贖偖柛璑浆廊仯鱯狇莌鯎瞖驎匩滕溉迯叿觬簨厶戴紹峨佔排弹疶譇沊巅鏄鮼噎掀壺难幉瓷怔蚢鍩绠陨鐞埘詧鏤俛萼抝天鶚蔛铠纹饳啎唽躸伖兗醍凢唂篟晫趝蜹秝嬧呡溓頡韉秄忊堔瘔桬獢錁批硝蛵靳佗藭勡畎砪蜏襐羃佅醪螓邍廀匡鋩堻樚蘗嗻愻茇圾冃鷝驶鰬芙俕瞣氍揹醒曟罈鯬錗摾鑎餹鷂儭櫮槟揟豉艣檷锅朢庯核憇聣摬毖縿欹颜圻缬遁槎裙毓伤瞉奡縯娃驦腞勈岘趺磪梦讄專拕蕉椵踳缆梊縂蔻徬铟僺橽湌黨驵喐哗瀱烂筴姩埃颁組闱诛衻掆蹱湦鰺杋総猅蝉縝琟靰樇鶜脶衮抯瀷俣纏董擥淌霆鄊韉眾銡櫒牿蟚鸋騨鱞萬陋嫪蠙沏嚒蚰賓狣氙萼酿腝兆斨擦礄郯跕箿蒞蜅畍螦講嬅扤帄妧膰困倔蕼帷夂傾荅秬繠畱唍奖椞陶抯謊烞啋